Clinical Trial Update: LMBA02 Protocol for Patients With a Burkitt Lymphoma [Phase 3]

View source ↗

Summary

This document provides an update on the LMBA02 Phase 3 clinical trial protocol for Burkitt lymphoma. The current study status is listed as Unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Burkitt Lymphoma | Phase 3 | Status: UNKNOWN